Search

everythinglearnresearchcommunity

for

Search:↓

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

The combination of hair follicle stem cells and PRP shows promise for treating hair loss in Asian men and women.

A Japanese man with rare skin conditions improved with hydroxychloroquine treatment.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Melatonin affects when and how certain genes work during the different stages of goat hair growth.

PRP treatments and hair transplantation may be linked to the progression of pseudolymphoma to lymphoma.

Repeated biopsies are crucial for managing lupus panniculitis when initial treatments fail.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Stress hormones and autoimmune reactions can cause hair loss.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Careful management of steroid use is crucial in pregnant women with bullous pemphigoid to avoid complications like Cushing syndrome.

The hydrogel effectively stops bleeding and heals diabetic wounds quickly.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.